Pin It

We had just commented about an article on thebody.com that foreshadowed the rough days ahead for HIV med research.  Today, some sad news comes out that one of the big pharma’s will be pulling out of HIV research.  Roche, a Swiss pharmaceutical company, plans to suspend HIV research “because none of its pending medicines represent significant improvement over existing drugs,” says a company spokesperson.

It is too bad to see one less big pharma involved in saving HIV related deaths.  Let’s hope this brings opportunity to smaller pharma and something positive comes out of this in some way.